• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近期诊断为2型糖尿病患者的糖尿病视网膜病变和黄斑水肿的患病率及相关危险因素

Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes.

作者信息

Graue-Hernandez Enrique O, Rivera-De-La-Parra David, Hernandez-Jimenez Sergio, Aguilar-Salinas Carlos A, Kershenobich-Stalnikowitz David, Jimenez-Corona Aida

机构信息

Departamento de Córnea y Cirugía Refractiva, Instituto de Oftalmología Fundación Conde de Valenciana IAP, Ciudad de México, México.

Instituto de Oftalmología Fundación Conde de Valenciana IAP, Ciudad de México, México.

出版信息

BMJ Open Ophthalmol. 2020 Mar 10;5(1):e000304. doi: 10.1136/bmjophth-2019-000304. eCollection 2020.

DOI:10.1136/bmjophth-2019-000304
PMID:32201732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7066603/
Abstract

OBJECTIVE

To determine the prevalence of diabetic retinopathy (DR) and diabetic macular oedema (DME) and their associated risk factors in patients recently diagnosed with type 2 diabetes.

METHODS AND ANALYSIS

We carried out a cross-sectional study from April 2014 to August 2017. We included patients aged ≥18 years. Diabetes was defined as fasting plasma glucose of >7.8 mmol/L or 2-hour postload plasma glucose of >11.1 mmol/L. Non-mydriatic fundus examination with a digital-fundus camera was performed. Three images centred in the macula, optic disc and temporal to the macula were obtained and graded according to the Scottish Scale Classification of Diabetic Retinopathy.

RESULTS

1232 patients (mean age 51.5 years) with a diabetes duration of 0-5 years were examined. Age-adjusted and sex-adjusted prevalence of DR and DME was 17.4% (95% CI 15.3% to 19.6%) and 6.6% (95% CI 5.4% to 8.2%), respectively. DR was associated with diabetes duration (OR per year=1.20, p<0.001), haemoglobin A1c (HbA1c) from 7.0 to 8.9 (OR=2.19, p<0.001), HbA1c≥9 (OR=2.98, p<0.001) and systolic blood pressure (SBP) (OR=1.16 per 5 mm Hg, p<0.001). DME was associated with diabetes duration (OR per year=1.26, p<0.01), HbA1c from 7.0 to 8.9 (OR=2.26, p<0.05), HbA1c≥9 (OR=2.38, p<0.01), SBP (OR per mm Hg=1.15, p<0.001) and albuminuria (OR=2.45, p<0.01).

CONCLUSION

Our study contributes to the evidence of progressive increase in DR and DME risk in early stages of diabetes, supporting the urgent need for early screening.

摘要

目的

确定近期诊断为2型糖尿病患者的糖尿病视网膜病变(DR)和糖尿病性黄斑水肿(DME)的患病率及其相关危险因素。

方法与分析

我们在2014年4月至2017年8月期间开展了一项横断面研究。纳入年龄≥18岁的患者。糖尿病定义为空腹血糖>7.8 mmol/L或餐后2小时血糖>11.1 mmol/L。使用数码眼底相机进行非散瞳眼底检查。获取以黄斑、视盘和黄斑颞侧为中心的三张图像,并根据糖尿病视网膜病变的苏格兰量表分类进行分级。

结果

对1232例糖尿病病程为0至5年(平均年龄51.5岁)的患者进行了检查。经年龄和性别调整后,DR和DME的患病率分别为17.4%(95%CI 15.3%至19.6%)和6.6%(95%CI 5.4%至8.2%)。DR与糖尿病病程(每年OR = 1.20,p<0.001)、糖化血红蛋白(HbA1c)7.0至8.9(OR = 2.19,p<0.001)、HbA1c≥9(OR = 2.98,p<0.001)以及收缩压(SBP)(每5 mmHg的OR = 1.16,p<0.001)相关。DME与糖尿病病程(每年OR = 1.26,p<0.01)、HbA1c 7.0至8.9(OR = 2.26,p<0.05)、HbA1c≥9(OR = 2.38,p<0.01)、SBP(每mmHg的OR = 1.15,p<0.001)以及蛋白尿(OR = 2.45,p<0.01)相关。

结论

我们的研究为糖尿病早期DR和DME风险逐渐增加的证据提供了补充,支持了早期筛查的迫切需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc9/7066603/bad194e4d214/bmjophth-2019-000304f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc9/7066603/bad194e4d214/bmjophth-2019-000304f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbc9/7066603/bad194e4d214/bmjophth-2019-000304f01.jpg

相似文献

1
Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes.近期诊断为2型糖尿病患者的糖尿病视网膜病变和黄斑水肿的患病率及相关危险因素
BMJ Open Ophthalmol. 2020 Mar 10;5(1):e000304. doi: 10.1136/bmjophth-2019-000304. eCollection 2020.
2
Risk Factors Associated with Diabetic Retinopathy with and without Macular Edema in Recently Diagnosed Patients with Type 2 Diabetes.近期诊断的2型糖尿病患者中伴或不伴黄斑水肿的糖尿病视网膜病变相关危险因素
Diabetes Metab Syndr Obes. 2024 Jan 16;17:231-238. doi: 10.2147/DMSO.S447658. eCollection 2024.
3
Non-mydriatic ultrawide field scanning laser ophthalmoscopy compared with dilated fundal examination for assessment of diabetic retinopathy and diabetic macular oedema in Chinese individuals with diabetes mellitus.非散瞳超广角激光扫描检眼镜与眼底散瞳检查在评估中国糖尿病患者糖尿病视网膜病变和糖尿病黄斑水肿中的比较。
Br J Ophthalmol. 2019 Sep;103(9):1327-1331. doi: 10.1136/bjophthalmol-2018-311924. Epub 2018 Oct 31.
4
Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study.中国南方 2 型糖尿病患者糖尿病视网膜病变和糖尿病黄斑水肿与肾功能的关系:一项单中心观察性研究。
BMJ Open. 2019 Sep 6;9(9):e031194. doi: 10.1136/bmjopen-2019-031194.
5
[Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].[2型糖尿病患者的糖尿病自我管理及其与糖尿病视网膜病变的关联]
Zhonghua Yan Ke Za Zhi. 2013 Jun;49(6):500-6.
6
Systemic risk factors contribute differently to the development of proliferative diabetic retinopathy and clinically significant macular oedema.系统性风险因素对增殖性糖尿病性视网膜病变和临床显著黄斑水肿的发展有不同的影响。
Diabetologia. 2020 Nov;63(11):2462-2470. doi: 10.1007/s00125-020-05234-0. Epub 2020 Jul 21.
7
Prevalence of and risk factors for diabetic macular edema in a northeastern Chinese population.中国东北地区人群糖尿病性黄斑水肿的患病率及危险因素
Int J Ophthalmol. 2022 Feb 18;15(2):320-326. doi: 10.18240/ijo.2022.02.19. eCollection 2022.
8
Prevalence and risk factors for diabetic retinopathy in a cross-sectional population-based study from rural southern China: Dongguan Eye Study.中国南方农村地区一项基于人群的横断面研究中糖尿病视网膜病变的患病率及危险因素:东莞眼病研究
BMJ Open. 2019 Sep 17;9(9):e023586. doi: 10.1136/bmjopen-2018-023586.
9
[Association of choroidal thickness with diabetic retinopathy at different stages].[不同阶段糖尿病视网膜病变与脉络膜厚度的相关性]
Zhonghua Yi Xue Za Zhi. 2015 Aug 25;95(32):2584-8.
10
Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study.空腹血糖波动是 2 型糖尿病患者发生糖尿病视网膜病变和糖尿病黄斑水肿的独立危险因素:一项为期 8 年的前瞻性队列研究。
Clin Exp Ophthalmol. 2020 May;48(4):470-476. doi: 10.1111/ceo.13728. Epub 2020 Feb 26.

引用本文的文献

1
Assessing variation in US payer coverage of anti-vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edema.评估美国医保支付方对用于治疗年龄相关性黄斑变性、糖尿病性视网膜病变和糖尿病性黄斑水肿的抗血管内皮生长因子疗法的覆盖范围差异。
J Manag Care Spec Pharm. 2025 May;31(5):451-460. doi: 10.18553/jmcp.2025.24340. Epub 2025 Apr 3.
2
Diabetic Macular Edema in the Western Part of Romania: Screening to Improve Patient Outcomes.罗马尼亚西部地区的糖尿病性黄斑水肿:进行筛查以改善患者预后。
J Pers Med. 2025 Mar 9;15(3):106. doi: 10.3390/jpm15030106.
3

本文引用的文献

1
The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals.在3年筛查间隔期间,选定的基层医疗中心糖尿病视网膜病变的患病率及危险因素。
J Family Med Prim Care. 2018 Sep-Oct;7(5):975-981. doi: 10.4103/jfmpc.jfmpc_85_18.
2
[Prevalence of previously diagnosed diabetes mellitus in Mexico.].[墨西哥既往诊断糖尿病的患病率。]
Salud Publica Mex. 2018 May-Jun;60(3):224-232. doi: 10.21149/8566.
3
Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA).
Burden of diabetic macular oedema and its associated factors among adult patients with diabetes attending comprehensive specialised hospitals in Northwest Ethiopia, 2023: a multicentre cross-sectional study.
2023年埃塞俄比亚西北部综合专科医院成年糖尿病患者糖尿病性黄斑水肿负担及其相关因素:一项多中心横断面研究
BMJ Open. 2025 Mar 15;15(3):e088507. doi: 10.1136/bmjopen-2024-088507.
4
Eye Axial Length: Is There a Protective Link to Diabetic Retinopathy?眼轴长度:与糖尿病性视网膜病变是否存在保护性关联?
Cureus. 2024 Dec 14;16(12):e75712. doi: 10.7759/cureus.75712. eCollection 2024 Dec.
5
Early response of anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) management: microperimetry and optical coherence tomography (OCT) findings: a pilot study at national eye center of third world country.抗血管内皮生长因子(anti-VEGF)在糖尿病性黄斑水肿(DME)治疗中的早期反应:微视野检查和光学相干断层扫描(OCT)结果:一个第三世界国家国家眼科中心的初步研究
BMC Ophthalmol. 2024 Dec 27;24(1):551. doi: 10.1186/s12886-024-03744-8.
6
Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Diabetic Retinopathy: An Attractive but Elusive Choice for Drug Development.聚(ADP-核糖)聚合酶-1(PARP-1)抑制剂在糖尿病视网膜病变中的应用:药物研发中一个有吸引力但难以捉摸的选择
Pharmaceutics. 2024 Oct 11;16(10):1320. doi: 10.3390/pharmaceutics16101320.
7
Predictors of Diabetic Retinopathy in Type 2 Diabetes: A Cross-Sectional Study.2型糖尿病患者糖尿病视网膜病变的预测因素:一项横断面研究。
Biomedicines. 2024 Aug 19;12(8):1889. doi: 10.3390/biomedicines12081889.
8
Rheumatoid arthritis and diabetic retinopathy: A two-sample Mendelian randomization study.类风湿关节炎与糖尿病视网膜病变:两样本孟德尔随机研究。
Medicine (Baltimore). 2024 Jul 26;103(30):e39001. doi: 10.1097/MD.0000000000039001.
9
Development and validation of a simple and practical model for early detection of diabetic macular edema in patients with type 2 diabetes mellitus using easily accessible systemic variables.开发并验证了一种简单实用的模型,可使用易于获得的系统变量早期检测 2 型糖尿病患者的糖尿病性黄斑水肿。
J Transl Med. 2024 May 31;22(1):523. doi: 10.1186/s12967-024-05328-y.
10
Prevalence and incidence of diabetic retinopathy in patients with diabetes of Latin America and the Caribbean: A systematic review and meta-analysis.拉丁美洲和加勒比地区糖尿病患者糖尿病视网膜病变的患病率和发病率:系统评价和荟萃分析。
PLoS One. 2024 Apr 4;19(4):e0296998. doi: 10.1371/journal.pone.0296998. eCollection 2024.
近期诊断为2型糖尿病(T2D)或成人隐匿性自身免疫性糖尿病(LADA)患者诊断时糖尿病视网膜病变(DRAD)的患病率及危险因素。
J Diabetes Complications. 2016 Nov-Dec;30(8):1456-1461. doi: 10.1016/j.jdiacomp.2016.08.009. Epub 2016 Aug 14.
4
Diabetic macular oedema.糖尿病性黄斑水肿。
Lancet Diabetes Endocrinol. 2017 Feb;5(2):143-155. doi: 10.1016/S2213-8587(16)30052-3. Epub 2016 Aug 3.
5
Diabetic retinopathy.糖尿病性视网膜病变。
Nat Rev Dis Primers. 2016 Mar 17;2:16012. doi: 10.1038/nrdp.2016.12.
6
Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.糖尿病视网膜病变:全球患病率、主要危险因素、筛查实践及公共卫生挑战:一项综述
Clin Exp Ophthalmol. 2016 May;44(4):260-77. doi: 10.1111/ceo.12696. Epub 2016 Feb 17.
7
Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates.墨西哥2型糖尿病负担:过去、当前及未来的患病率和发病率
Prev Med. 2015 Dec;81:445-50. doi: 10.1016/j.ypmed.2015.10.015. Epub 2015 Nov 7.
8
Implication of oxidative stress in progression of diabetic retinopathy.氧化应激在糖尿病性视网膜病变进展中的意义。
Surv Ophthalmol. 2016 Mar-Apr;61(2):187-96. doi: 10.1016/j.survophthal.2015.06.001. Epub 2015 Jun 11.
9
The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients.中国2型糖尿病患者糖尿病视网膜病变的5年发病与转归情况
PLoS One. 2014 Nov 17;9(11):e113359. doi: 10.1371/journal.pone.0113359. eCollection 2014.
10
Innovative models for the empowerment of patients with type 2 diabetes: the CAIPaDi program.2型糖尿病患者赋权创新模式:CAIPaDi项目
Recent Pat Endocr Metab Immune Drug Discov. 2014;8(3):202-9. doi: 10.2174/1872214808999141110155515.